Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine – Reuters
NEW YORK, Jan 25 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicr… [+3379 metas 2022]